After a few years of basic research and evaluation of possible alternatives, in 2012 we began the technological development and clinical studies of the solution with laser application. A priori it offered two clear advantages over the previous solutions, greater security because it is not a surgical intervention, and naturalness the result, sinve it yields biological tissue colors of the patient itself and does not alterate the functionality of the pupil, which continues to react to light and darkness in a normal way [14,15]. Thus, visual aberrations and limitations of the peripheral visual fi eld are avoided. The premises of the project were defi ned but should be demonstrated over the following years. Several phases were planned: First phase of safety assessment: 2012-2014 Second phase of effectiveness and predictability: 2014-2016 Third phase of technological improvement: 2017-2018 Fourth phase of technical sophistication: 2019-2020.

Fortunately, our premises were confi rmed over time and, not without big effort, we were able to solve the problems
we encountered on the road and achieve a state close to the excellence of the original technique. This is the summary of the last 7 years of scientifi c, clinical and technological progress, similar to that performed in the past with cataract surgery (intracapsular, extracapsular, intraocular lenses, phacoemulsifi cation, femtolaser) or refractive

No Comments

Sorry, the comment form is closed at this time.